Daniel Matthias Aebersold (Daniel M Aebersold)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Topics

Tyrosine Kinase

Radical Prostatectomy

Radiation Induced

Dna Damage Response

Top Venues

Prostate cancer and prostatic diseases

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. Cancer research communications 4 (7) (2024)
Ali Janbain, Andrea Farolfi, Armelle Arnoux, Louis Romengas, Sophia Scharl, Stefano Fanti, Francesca Serani, Jan C Peeken, Sandrine Katsahian, Iosif Strouthos, Konstantinos Ferentinos, Stefan A Koerber, Marco M E Vogel, Stephanie Elisabeth Combs, Alexis Vrachimis, Alessio Giuseppe Morganti, Simon K B Spohn, Anca-Ligia Grosu, Francesco Ceci, Christoph Henkenberens, Stephanie G C Kroeze, Matthias Guckenberger, Claus Belka, Peter Bartenstein, George Hruby, Louise Emmett, Ali Afshar Omerieh, Nina-Sophie Schmidt-Hegemann, Lucas Mose, Daniel Matthias Aebersold, Constantinos Zamboglou, Thomas Wiegel, Mohamed Shelan
A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET-Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective Study. JMIR cancer 10 (2024)
Mohamed Shelan, Vérane Achard, Felix Appiagyei, Lucas Mose, Thomas Zilli, Christian D Fankhauser, Constantinos Zamboglou, Osama Mohamad, Daniel Matthias Aebersold, Richard Cathomas
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases 27 (3) (2024)
Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. Cancer research communications 4 (7) (2024)
Mohamed Shelan, Vérane Achard, Felix Appiagyei, Lucas Mose, Thomas Zilli, Christian D Fankhauser, Constantinos Zamboglou, Osama Mohamad, Daniel Matthias Aebersold, Richard Cathomas
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases 27 (3) (2024)
Mohamed Shelan, Vérane Achard, Felix Appiagyei, Lucas Mose, Thomas Zilli, Christian D Fankhauser, Constantinos Zamboglou, Osama Mohamad, Daniel Matthias Aebersold, Richard Cathomas
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases (2024)
Matthias Guckenberger, Charlotte Billiet, Daniel Schnell, Ciro Franzese, Mateusz Jacek Spałek, Susanne Rogers, Jean-Jacques Stelmes, Daniel Matthias Aebersold, Hossein Hemmatazad, Frank Zimmermann, Jörg Zimmer, Thomas Zilli, Alessio Bruni, Brigitta Gertrud Baumert, Franziska Nägler, Philipp Gut, Robert Förster, Indira Madani
Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial. Cancer (2024)
Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-associated purine synthesis pathway is a major component of the MET-DNA damage response network. Cancer research communications (2024)
Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. Cancer research communications 4 (7) (2024)
Matthias Guckenberger, Charlotte Billiet, Daniel Schnell, Ciro Franzese, Mateusz Jacek Spałek, Susanne Rogers, Jean-Jacques Stelmes, Daniel Matthias Aebersold, Hossein Hemmatazad, Frank Zimmermann, Jörg Zimmer, Thomas Zilli, Alessio Bruni, Brigitta Gertrud Baumert, Franziska Nägler, Philipp Gut, Robert Förster, Indira Madani
Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial. Cancer 130 (15) (2024)
Mohamed Shelan, Vérane Achard, Felix Appiagyei, Lucas Mose, Thomas Zilli, Christian D Fankhauser, Constantinos Zamboglou, Osama Mohamad, Daniel Matthias Aebersold, Richard Cathomas
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases 27 (3) (2024)
Hannes A Loebner, Silvan Mueller, Werner Volken, Philipp Wallimann, Daniel Matthias Aebersold, Marco F M Stampanoni, Michael K Fix, Peter Manser
Impact of the gradient in gantry-table rotation on dynamic trajectory radiotherapy plan quality. Medical physics (2023)
Robert Poel, Amith J Kamath, Jonas Willmann, Nicolaus Andratschke, Ekin Ermiş, Daniel Matthias Aebersold, Peter Manser, Mauricio Reyes
Deep-Learning-Based Dose Predictor for Glioblastoma-Assessing the Sensitivity and Robustness for Dose Awareness in Contouring. Cancers 15 (17) (2023)
Christina Schröder, Lucas Mose, Etienne Mathier, Daniel Rudolf Zwahlen, Daniel Matthias Aebersold, Robert Foerster, Mohamed Shelan
Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis. Cancers 15 (24) (2023)
Erwin Vu, Nina Steinmann, Christina Schröder, Robert Foerster, Daniel Matthias Aebersold, Steffen Eychmüller, Nikola Cihoric, Caroline Hertler, Paul Windisch, Daniel Rudolf Zwahlen
Applications of Machine Learning in Palliative Care: A Systematic Review. Cancers 15 (5) (2023)
Christina Schröder, Lucas Mose, Etienne Mathier, Daniel Rudolf Zwahlen, Daniel Matthias Aebersold, Robert Foerster, Mohamed Shelan
Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis. Cancers 15 (24) (2023)
Christina Schröder, Lucas Mose, Etienne Mathier, Daniel Rudolf Zwahlen, Daniel Matthias Aebersold, Robert Foerster, Mohamed Shelan
Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis. Cancers 15 (24) (2023)
Erwin Vu, Nina Steinmann, Christina Schröder, Robert Foerster, Daniel Matthias Aebersold, Steffen Eychmüller, Nikola Cihoric, Caroline Hertler, Paul Windisch, Daniel Rudolf Zwahlen
Applications of Machine Learning in Palliative Care: A Systematic Review. Cancers 15 (5) (2023)
Daniel H Schanne, Alexander Koch, Olgun Eliçin, Roland Giger, Michaela Medová, Yitzhak Zimmer, Daniel Matthias Aebersold
Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy-A Systematic Review. Biomedicines 10 (12) (2022)
Daniel Wegener, Daniel Matthias Aebersold, Marc-Oliver Grimm, Peter Hammerer, Michael Froehner, Markus Graefen, Dirk Boehmer, Daniel Zips, Thomas Wiegel
Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage. Biomedicines 10 (9) (2022)
Daniel H Schanne, Alexander Koch, Olgun Eliçin, Roland Giger, Michaela Medová, Yitzhak Zimmer, Daniel Matthias Aebersold
Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy-A Systematic Review. Biomedicines 10 (12) (2022)
Nikola Cihoric, Eugenia Vlaskou Badra, Anna Stenger-Weisser, Daniel Matthias Aebersold, Matea Pavic
Toward Data-Driven Radiation Oncology Using Standardized Terminology as a Starting Point: Cross-sectional Study. JMIR formative research 6 (1) (2022)
Fritz Rigendinger, Daniel Matthias Aebersold, Željka Cvejić, Bojan Pajic
Changes of Corneal Biomechanical Properties upon Exclusive Ytt-/Sr-90 Irradiation of Pterygium. Sensors (Basel, Switzerland) 21 (3) (2021)
Lluís Nisa, Paola Francica, Roland Giger, Matúš Medo, Olgun Eliçin, Manja Friese-Hamim, Claudia Wilm, Christopher Stroh, Beat Bojaxhiu, Aurélie Quintin, Marco D Caversaccio, Matthias S Dettmer, Mélanie Buchwalder, Tess M Brodie, Daniel Matthias Aebersold, Yitzhak Zimmer, Thomas E Carey, Michaela Medová
Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma. Molecular cancer therapeutics 19 (2) (2019)